English
Home
About CPF
About Us
CPF R&D
Factory Style
Video
Products
FAQs
News
Company News
Industry News
Contact Us
Home
Products
O
Orforglipron (CAS: 2212020-52-3)
Short Description:
API’s Name
CAS No.
US DMF
EU DMF
Patent Expiry Date(US)
Orforglipron
2212020-52-3
Nov, 2026
Sep.26,2037
[
Product
] Provide the API as well as the SDD (Spray Dried Dispersion)
[
Indication
]
Type 2 diabetes mellitus:To improve glycemic control in adults with type 2 diabetes mellitus.
For clinical research, now it can be used for Chronic weight management in adults.
Send email to us
Product Detail
Product Tags
Previous:
Osimertinib (CAS: 1421373-66-1)
Next:
Suzetrigine (CAS: 2649467-58-1)
2212020-52-3
China Wholesale Orforglipron Suppliers
GLP-1 receptor agonist 1
LY3502970
Orforglipron factory
Orforglipron manufacturer
Write your message here and send it to us
Products categories
Osimertinib (CAS: 1421373-66-1)
Oteseconazole (CAS: 1340593-59-0)
Obeticholic Acid
Hit enter to search or ESC to close
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur